BLUE - Stock Risk Analysis Report for BLUEBIRD BIO INC

BLUE Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Bluebird Bio Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how BLUE stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Biological Product (except Diagnostic) Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo bluebird bio is pioneering gene therapy with purpose. From its Cambridge, Mass., headquarters, they're developing gene and cell therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond their labs, the company is working to positively disrupt the healthcare system to create access, transparency and education so that gene therapy can become available to all those who can benefit.

Identity

Symbol: BLUE
FactorPad FPID: f99dpp
SEC CIK: 0001293971
Share Class FIGI: BBG001T91ZT6
Location: None, None None
Web: www.bluebirdbio.com

Sector and Industry

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
SIC Code: 2836

Share Data

Shares Outstanding: 67,578,549

Earnings and Dividends

Trailing 12-month earnings: -12.61
Next earnings date: 2021-11-04

Dividend yield in last 12 months: 0%
Ex-dividend date:

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Beta: 0.54 | All: 7 | Sector: 8 | Industry: 13

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Market Capitalization: $1,246,148,444 | All: 85 | Sector: 83 | Industry: 88

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Daily Dollar Volume: $19,202,524 | All: 63 | Sector: 63 | Industry: 71

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Stock Price Change (1-Year): -64.3% | All: 100 | Sector: 100 | Industry: 100

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Earnings Yield (E/P): -67.58% | All: 100 | Sector: 100 | Industry: 100

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

Dividend Yield (D/P): 0% | All: 81 | Sector: 76 | Industry: 59

Stock Risk Measures for Bluebird Bio Inc